Synthesis and pharmacology of 3-hydroxy-Δ2-isoxazoline-cyclopentane analogues of glutamic acid

被引:10
作者
Conti, P
De Amici, M
Bräuner-Osborne, H
Madsen, U
Toma, L
De Micheli, C
机构
[1] Univ Milan, Ist Chim Farmaceut, I-20131 Milan, Italy
[2] Royal Danish Sch Pharm, Dept Med Chem, DK-2100 Copenhagen, Denmark
[3] Univ Pavia, Dipartimento Chim Organ, I-27100 Pavia, Italy
来源
FARMACO | 2002年 / 57卷 / 11期
关键词
1,3-dipolar cycloaddition; isoxazoline-cyclopentane amino acids; ionotropic glutamic acid receptors; metabotropic glutamic acid receptors; NMDA agonist;
D O I
10.1016/S0014-827X(02)01307-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The synthesis and pharmacology of two potential glutamic acid receptor ligands are described. Preparation of the bicyclic 3-hydroxy-Delta(2)-isoxazoline-cyclopentane derivatives (+/-)-7 and (+/-)-8 was accomplished via 1,3-dipolar cycloaddition of bromonitrile oxide to suitably protected 1-amino-cyclopent-3-enecarboxylic acids. Their structure was established using a combination of H-1 NMR spectroscopy and molecular mechanics calculations carried out on the intermediate cycloadducts (+/-)-11 and (+/-)-12. Amino acid derivatives (+/-)-7 and (+/-)-8 were assayed at ionotropic and metabotropic glutamic acid receptor subtypes and their activity compared with that of trans-ACPD and cis-ACPD. The results show that the replacement of the omega-carboxylic group of the model compounds with the 3-hydroxy-Delta(2)-isoxazoline moiety abolishes or reduces drastically the activity at the metabotropic glutamate receptors. Conversely, on passing from cis-ACPD to derivative (+/-)-8, the agonist activity at NMDA receptors is almost unaffected. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights.
引用
收藏
页码:889 / 895
页数:7
相关论文
共 35 条
[1]  
[Anonymous], DRUG NEWS PERSPECT
[2]   INHIBITION OF [H-3] KAINIC ACID RECEPTOR-BINDING BY DIVALENT-CATIONS CORRELATES WITH ION AFFINITY FOR THE CALCIUM-CHANNEL [J].
BRAITMAN, DJ ;
COYLE, JT .
NEUROPHARMACOLOGY, 1987, 26 (09) :1247-1251
[3]   Ligands for glutamate receptors:: Design and therapeutic prospects [J].
Bräuner-Osborne, H ;
Egebjerg, J ;
Nielsen, EO ;
Madsen, U ;
Krogsgaard-Larsen, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2609-2645
[4]   A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid [J].
Brauner-Osborne, H ;
Slok, FA ;
Skjaerbaek, N ;
Ebert, B ;
Sekiyama, N ;
Nakanishi, S ;
KrogsgaardLarsen, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) :3188-3194
[5]  
CARAMELLA P, 1974, TETRAHEDRON LETT, V2, P229
[6]   Pharmacology and functions of metabotropic glutamate receptors [J].
Conn, PJ ;
Pin, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237
[7]   Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists [J].
Conti, P ;
De Amici, M ;
De Sarro, G ;
Rizzo, M ;
Stensbol, TB ;
Bräuner-Osborne, H ;
Madsen, U ;
Toma, L ;
De Micheli, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) :4099-4107
[8]   Synthesis of new bicyclic analogues of glutamic acid [J].
Conti, P ;
Dallanoce, C ;
De Amici, M ;
De Micheli, C ;
Fruttero, R .
TETRAHEDRON, 1999, 55 (17) :5623-5634
[9]  
CURRAN DP, 1993, HETEROCYCLES, V35, P1371
[10]   DIRECTED NITRILE OXIDE CYCLOADDITION REACTIONS - THE USE OF HYDROGEN-BONDING TO DIRECT REGIOCHEMISTRY AND STEREOCHEMISTRY IN NITRILE OXIDE CYCLOADDITIONS WITH CYCLOPENTENYLAMIDES [J].
CURRAN, DP ;
CHOI, SM ;
GOTHE, SA ;
LIN, FT .
JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (12) :3710-3712